Optiscan in the news: Aussie made: ASX firms boosting local health & medical manufacturing

779dad55f1b93cc3e56b27b0110fc02c

Optiscan (ASX: OIL) has been included in an article published in both The Australian and Stockhead highlighting local health and medtech companies embracing opportunities to manufacture products in Australia.

The piece underscores the innovative nature of Optiscan's telepathology platform, which allows for real-time, non-invasive imaging at the single-cell level.

"OIL, is a global leader in developing, manufacturing, and commercialising confocal endomicroscopy imaging technologies for medical, translational, and pre-clinical applications. The company's technology, known as optical biopsy, generates real-time microscopic images, potentially eliminating the need for physical biopsies."

Read the full articles here:

The Australian

Stockhead

Select Category